Treatment progress of cancer-related anemia / 肿瘤研究与临床

ABSTRACT

Cancer-related anemia (CRA) is a complication of tumor patients in the development and treatment of diseases. Studies have shown that the incidence of anemia in non-hematologic malignancies is about 40％, and the incidence can reach 54％during tumor radiotherapy and chemotherapy. The pathogenesis of CRA has not been fully clarified, and studies at home and abroad are also very limited. The quality of life and prognosis of CRA patients are poor. In China, due to the imbalance of economic level and the development of medical conditions, doctors in different levels of medical units have different levels of understanding and attention to CRA. Therefore, it is particularly important to strengthen the standardized diagnosis and treatment of CRA. The effectiveness and safety of the presently accepted therapeutic approaches are defined. The new treatment methods are still in the research stage. The article reviews the status of diagnosis and treatment of CRA.